August 22, 2023

Revolutionizing Commercial Aliquotation in Advanced Therapies

Modular filling enabling process flexibility for viral vector manufacturing

We are thrilled to unveil our latest customized innovation within the product range of automated aliquoting systems, RoSS.FILL. This groundbreaking solution is set to redefine the way small volumes are dispensed into single-use bags at a commercial scale. With its unmatched precision and cutting-edge technology, RoSS.FILL CGT is a game-changer for the cell and gene therapy industry.

Many Bags. Small Volumes.

At Single Use Support, we understand the critical importance of accuracy and efficiency in the manufacturing process of advanced therapies, including non-viral and viral vectors. Thanks to the modularity of the RoSS.FILL platforms, it is possible to address the unique challenges faced by researchers and manufacturers in this rapidly advancing field. 

Filling up to 126 single-use bioprocess containers with 3mL to 100mL each, this revolutionary system sets a new standard for precision and reliability.

Highest Precision

RoSS.FILL CGT leverages state-of-the-art technology to ensure that even the smallest volumes are handled with utmost precision. Using flow sensors, filling accuracy can be between ±0.6mL and ±3mL, when using typical filling volumes. Whether you are working with delicate gene therapies or intricate cell-based products, this modular solution guarantees accurate aliquotation and filling, eliminating the risk of variability and ensuring consistent product quality. The system is engineered to seamlessly integrate into existing workflows, allowing for effortless scalability and enhanced productivity. Say goodbye to complex and time-consuming manual processes and embrace a new era of efficiency.

Pioneering the biopharmaceutical industry, Single Use Support takes pride in developing innovative solutions that empower researchers and manufacturers to push the boundaries of possibility. RoSS.FILL CGT is a testament to our commitment to advancing the field of cell and gene therapies. Join us on this remarkable path and unlock the full potential of your cell and gene therapy manufacturing.

viral vectors gene therapy 3 aav

Viral vectors for gene therapy: What to expect in 2023

Viral vectors are looking ahead a bright future in gene therapies. In this article, we give you an overview of the most frequently used viral vectors and have a glimpse at their possible future applications.

Gene therapy manufacturing-5 requirements to scale up

Gene therapy manufacturing - 5 requirements to scale up

Gene therapies have become a highly promising field of groundbreaking next generation treatment, but there are some challenges to face within the manufacturing process. Here are 5 factors that will be crucial for upscaling gene therapy manufacturing with single-use technology.

Automated filling and draining system for CGT - RoSS.FILL CGT

Single Use Support providing solutions for gene therapies

Biopharma solution provider Single Use Support announces an order from Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO).

Non-viral vectors in gene therapy

Non-viral vectors in gene therapy: LNPs in the spotlight

Non-viral vectors play an increasingly important role in biomedical research and therapy, including gene therapy. In this article, we will discuss the role of non-viral vectors for this specific purpose.

Viral vector simply explained

Viral vector simply explained

Viral vectors have become an indispensable tools in therapeutic and research applications. In this article, we will provide a broad overview of this fascinating topic.

Viral vector manufacturing: Production methods & future advances

Viral vector manufacturing: Production methods & future advances

Viral vector manufacturing involves advanced biotechnological methods, with scalability being one of the major difficulties. In this article, we will discuss both challenges and innovative approaches for viral vector production.

RoSS.FILL CGT Small Volumne_Product Photo-3-min

Brian Moloney

Director New Products, Innovation & Product Line Management

Did you enjoy this article? Share it with others!